skip to Global Navigation Bar skip to main content


homeHome > About Us > Press Release > News

News

News Content
Daewoong’s ‘NABOTA’ submitted the form to change clinical test plans in China.
Date 2019-01-07 Hit 1874
list
News List
Prev DAEWOONG Pharmaceutical’s New Year’s greetings: “The year 2019 will be the first year of our challenge to be a global healthcare group”
Next Daewoong Pharmaceutical leads innovation of local business by focusing on technology transfer with Trapaco, the largest pharmaceuticals company in Vietnam.